204 related articles for article (PubMed ID: 18684965)
1. Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells.
Kochetkova I; Trunkle T; Callis G; Pascual DW
J Immunol; 2008 Aug; 181(4):2741-52. PubMed ID: 18684965
[TBL] [Abstract][Full Text] [Related]
2. Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis.
Kochetkova I; Thornburg T; Callis G; Pascual DW
J Immunol; 2011 Nov; 187(9):4654-66. PubMed ID: 21967895
[TBL] [Abstract][Full Text] [Related]
3. IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen.
Ochoa-Repáraz J; Rynda A; Ascón MA; Yang X; Kochetkova I; Riccardi C; Callis G; Trunkle T; Pascual DW
J Immunol; 2008 Jul; 181(2):954-68. PubMed ID: 18606647
[TBL] [Abstract][Full Text] [Related]
4. Oral Escherichia coli colonization factor antigen I fimbriae ameliorate arthritis via IL-35, not IL-27.
Kochetkova I; Thornburg T; Callis G; Holderness K; Maddaloni M; Pascual DW
J Immunol; 2014 Jan; 192(2):804-16. PubMed ID: 24337375
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis.
Ochoa-Repáraz J; Riccardi C; Rynda A; Jun S; Callis G; Pascual DW
J Immunol; 2007 Feb; 178(3):1791-9. PubMed ID: 17237429
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo.
Jaen O; Rullé S; Bessis N; Zago A; Boissier MC; Falgarone G
Immunology; 2009 Jan; 126(1):35-44. PubMed ID: 18754812
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.
Bashi T; Shovman O; Fridkin M; Volkov A; Barshack I; Blank M; Shoenfeld Y
Clin Exp Immunol; 2016 Apr; 184(1):19-28. PubMed ID: 26618631
[TBL] [Abstract][Full Text] [Related]
8. Immunization with TCR Vbeta10 peptide reduces the frequency of type-II collagen-specific Th1 type T cells in BUB/BnJ (H-2q) mice.
Anthony DD; Heeger PS; Haqqi TM
Clin Exp Rheumatol; 2001; 19(4):385-94. PubMed ID: 11491493
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.
Park MJ; Min SY; Park KS; Cho YG; Cho ML; Jung YO; Park HS; Chang SH; Cho SG; Min JK; Park SH; Kim HY
Arthritis Res Ther; 2008; 10(1):R11. PubMed ID: 18221522
[TBL] [Abstract][Full Text] [Related]
10. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.
Xiao Z; Juan L; Song Y; Zhijian Z; Jing J; Kun Y; Yuna H; Dongfa D; Lili D; Liuxin T; Fei L; Nan L; Fang Y; Yuying S; Yongzhi X
Hum Vaccin Immunother; 2015; 11(4):938-45. PubMed ID: 25763999
[TBL] [Abstract][Full Text] [Related]
12. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
Kelchtermans H; Geboes L; Mitera T; Huskens D; Leclercq G; Matthys P
Ann Rheum Dis; 2009 May; 68(5):744-50. PubMed ID: 18480308
[TBL] [Abstract][Full Text] [Related]
13. Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector.
Pascual DW; White MD; Larson T; Walters N
J Immunol; 2001 Jul; 167(1):407-15. PubMed ID: 11418677
[TBL] [Abstract][Full Text] [Related]
14. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.
Morgan ME; Sutmuller RP; Witteveen HJ; van Duivenvoorde LM; Zanelli E; Melief CJ; Snijders A; Offringa R; de Vries RR; Toes RE
Arthritis Rheum; 2003 May; 48(5):1452-60. PubMed ID: 12746920
[TBL] [Abstract][Full Text] [Related]
15. Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma.
Kelchtermans H; De Klerck B; Mitera T; Van Balen M; Bullens D; Billiau A; Leclercq G; Matthys P
Arthritis Res Ther; 2005; 7(2):R402-15. PubMed ID: 15743488
[TBL] [Abstract][Full Text] [Related]
16. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
17. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
18. Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis.
Asnagli H; Martire D; Belmonte N; Quentin J; Bastian H; Boucard-Jourdin M; Fall PB; Mausset-Bonnefont AL; Mantello-Moreau A; Rouquier S; Marchetti I; Jorgensen C; Foussat A; Louis-Plence P
Arthritis Res Ther; 2014 May; 16(3):R115. PubMed ID: 24886976
[TBL] [Abstract][Full Text] [Related]
19. Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant.
Wu HY; Maron R; Tukpah AM; Weiner HL
J Immunol; 2010 Sep; 185(6):3401-7. PubMed ID: 20720210
[TBL] [Abstract][Full Text] [Related]
20. Tolerance in the absence of autoantigen.
Pascual DW; Ochoa-Repáraz J; Rynda A; Yang X
Endocr Metab Immune Disord Drug Targets; 2007 Sep; 7(3):203-10. PubMed ID: 17897047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
